{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:46Z","timestamp":1753891306395,"version":"3.41.2"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>A 42 year-old male with prurigo nodularis treated with dupilumab showed a case of linear psoriasis, highlighting the potential of dupilumab to induce immune shift and chimeric gene expression.<\/jats:p>","DOI":"10.3389\/fmed.2024.1527257","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T05:14:53Z","timestamp":1737954893000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report: Dupilumab-induced linear psoriasis: a rare presentation"],"prefix":"10.3389","volume":"11","author":[{"given":"Wen","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuekang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huajie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37992","article-title":"Dupilumab-induced scalp psoriasis in a patient with prurigo nodularis: A case report.","volume":"15","author":"Hawsawi","year":"2023","journal-title":"Cureus."},{"key":"B2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jdcr.2024.06.044","article-title":"Paradoxical psoriasis after dupilumab treatment of prurigo nodularis treated with adalimumab.","volume":"52","author":"S\u00f8rensen","year":"2024","journal-title":"JAAD Case Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/bjd\/ljae052","article-title":"Prurigo nodularis: New insights into pathogenesis and novel therapeutics.","volume":"190","author":"Liao","year":"2024","journal-title":"Br J Dermatol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1092685","article-title":"Dupilumab for the treatment of prurigo nodularis: A systematic review.","volume":"14","author":"Cao","year":"2023","journal-title":"Front Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s40272-022-00531-0","article-title":"Dupilumab treatment in children aged 6-11 years with atopic dermatitis: A multicentre, real-life study.","volume":"24","author":"Napolitano","year":"2022","journal-title":"Paediatr Drugs."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13502","article-title":"Dupilumab and COVID-19: What should we expect?","volume":"33","author":"Patruno","year":"2020","journal-title":"Dermatol Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.jaad.2021.01.012","article-title":"Facial and neck erythema associated with dupilumab treatment: A systematic review.","volume":"84","author":"Jo","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15117","article-title":"Dupilumab-induced Urticaria.","volume":"34","author":"Mastorino","year":"2021","journal-title":"Dermatol Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.23736\/S2784-8671.21.07070-5","article-title":"Lichen ruber planus arising during dupilumab treatment for atopic dermatitis.","volume":"157","author":"Mastorino","year":"2022","journal-title":"Ital J Dermatol Venerol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1111\/ced.13901","article-title":"Psoriasis induced by dupilumab therapy.","volume":"44","author":"Safa","year":"2019","journal-title":"Clin Exp Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jdcr.2018.05.014","article-title":"Erythrodermic presentation of psoriasis in a patient treated with dupilumab.","volume":"4","author":"Tracey","year":"2018","journal-title":"JAAD Case Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.2147\/JIR.S476297","article-title":"Pustular psoriasis induced by dupilumab: A case report.","volume":"17","author":"Liu","year":"2024","journal-title":"J Inflamm Res."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.28.5.337","article-title":"Somatic recombination may explain linear psoriasis.","volume":"28","author":"Happle","year":"1991","journal-title":"J Med Genet."},{"key":"B14","first-page":"38","article-title":"Lithium-induced linear psoriasis: A rare presentation.","volume":"12","author":"Garg","year":"2019","journal-title":"J Clin Aesthet Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.lungcan.2020.06.012","article-title":"Pembrolizumab-induced linear psoriasis.","volume":"146","author":"Huang","year":"2020","journal-title":"Lung Cancer."},{"key":"B16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1159\/000530608","article-title":"Dupilumab-associated psoriasis and psoriasiform manifestations: A scoping review.","volume":"239","author":"Su","year":"2023","journal-title":"Dermatology."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.932766","article-title":"Case report: Clinical and histopathological characteristics of psoriasiform erythema and de novo IL-17A cytokines expression on lesioned skin in atopic dermatitis children treated with dupilumab.","volume":"9","author":"Ali","year":"2022","journal-title":"Front Med (Lausanne)."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15788","article-title":"Psoriasiform dermatitis induced by dupilumab successfully treated with upadacitinib.","volume":"35","author":"Patruno","year":"2022","journal-title":"Dermatol Ther."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1527257\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T05:14:56Z","timestamp":1737954896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1527257\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":18,"alternative-id":["10.3389\/fmed.2024.1527257"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1527257","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"article-number":"1527257"}}